Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Continued answers based on opinions are speculation until reality occurs. No one is forced to accept the risks. No rewards or losses are guaranteed.
I sold my small piece of that comparison's stock. That doesn't mean a forever decision or some need to post a public kabitz on the way I 'might' have handled things IF I was the CEO. Certainly no need for publicly ranted tantrums.
Folks have to make decisions sometimes in spite of personal opinions or hope or attitudes. Doing nothing is also a decision. I have mentioned personal responsibility for actions before.
Any poster's claimed position, actions or opinionated hind-sights and speculations of different futures are all worth the same to others, IMHFO.
So sad there are many dissuaded from contributing to this forum...GLTA...
Which program or programs have been identified by AGN as the first with the needed MHRA/FDA approvals to move forward and specific plans the financing will cover.?.*
Just raise money on a handshake? 'Go for it guys', here's $9M.
$9M from one source, all at once, to spend any which way? From 'friends and family/cobras/Caymen Isls'.?. No specifics? No sponsors or partnerships? No plans, timelines or time for PR pumps to raise the PPS/MC first?
Investors and financiers usually support stocks they Like and understand. Plenty other stocks out there, no need to hate an investment, people can just sell, take a loss and not worry anymore. Holding is an active investment action.
*Financing a company's future efforts and goals is proportionately a much larger action? An IPO is an even larger action still, not some casual headfake.
But Interesting forecasts are allowed and the Right to 'opine' has been earned in blood and sacrifice in My America.
This shareholder expects microdose DMT through Hammerschmidt will be first program and have proper pump and circumstance.
...GLTA...
Google the quote. I dont pump competition or comparisons.
That Capitol raise is Conditional on the move to nasdaq. Not before.......
Read...
As a comparison there is a company that "effectively destroyed cancer cells grown in culture" with a 4X+ in the last couple days. 70M MC and climbing.
AGN has gone past that milestone on ALL it's programs with murine testing (etc) and proof of concept/MOA enough to start New ones and move forward with other Human Clinical trials.
Pretty much a 'when' and 'which' question.
When that is set I hope for a much better PPS and leverage for raising money/IPO/2+ for 1...liquidity.?.
Second Phase 2 clinical trial data due.
So far.
A Full Plate for the next couple years.
A fair Speculative investment, IMO. I am holding. Every one has the Right to 'opine' their crystal balls...
...GLTA...
Canada allows Psilocybin for terminal Cancer patients. Other indications to follow.?. Stroke?
Sub hallucinogenic dosed DMT @ Algernon, Clinical Trial applications' approval or denial due.
https://www.msn.com/en-us/money/other/6-terminally-ill-cancer-patients-in-canada-received-doses-of-the-psychoactive-substance-found-in-magic-mushrooms-after-authorities-eased-rules/ar-AAVXb5R?ocid=msedgdhp&pc=U531&cvid=799f8df25d2742ce99fa6e49b7e35605
A $50M MC is the initial target and presumes an MHRA approval for their sub hallucinogenic dose DMT Trials.
Raising money, attracting sponsors, bonuses and shareholder reward at an IPO.
...Buy-Hold-Sell...GLTA...
More emphasis on the "effective at a sub-psychedelic dose" stuff and some specific explanations/pitch/pump of that core theory...Please...
This PR seems to indicate expected good results from the MHRA for continuation of their Trial plans. Why else a DMT video.?.
...GLTA...
As one of the most published scientists on the effects of psychedelics, Johnson explains the medicine is potentially working on two levels.
“There’s depression and addiction treatment … where a number of published studies have shown psychedelic treatment to be extremely promising in comparison with SSRIs like prozac. The other category, though, is neurological.”
Johnson explains studies like those conducted by the University of California, have found psychedelic treatments to induce neuroplastic effects in brains of rats.
“Their brains seem to be rewiring and healing,” he says of the exploratory work that has not yet been tested on humans.
While Johnson is careful not to encourage any use of psychedelics outside of research environments, or to suggest their ability to rebuild brains is anything other than theoretical, he remains excited by the potential the future offers.
https://www.theguardian.com/sport/2021/jun/14/psychedelics-boxing-brain-trauma-mike-tyson-therapeutic-use
Thanks for a reply, anyway.
I feel forced to reply in rebuttal to some questionable posts, as otherwise, there would only be one dominating opinion with no debate.
Do you see possible future successes with Agn and their current initiatives?
Buy/hold/sell recommendations? Your personal positions?
Thanks, tcm7...
...GLTA...
Some interesting of Bth/NASH/Agn chart (?) analysis with emotional accents.
A cooperative relationship with BLO to use Bth's medical Breathalyzer (Yost) FAIMS research made sense to me after the '18/'19 Pot runups. An easier target than THC9 and it woulda/coulda/shoulda have been relevant as the COVID pandemic started
But
It's 2022 now.
But.
We all wish for successful repurposing Drug strategies with IBD/IPF/CKD as the company had to change directions. IMO..
COVID came as Agn prioritized IPF/CC and we all wished for Ifenprodil to quickly move through Clinical Trials in South Korea and internationally.
Delay issues finally led to the 'expected' Dec 2020 interim review (fiasco) trying 'to keep Agn's COVID efforts relevant" as the first wave waned and vaccines became available.
Ifenprodil did not prove effective enough for COVID type illnesses specifically and costs/medical needs made a Phase 3 CT not a viable direction.
Some of the positive data from that CT relates to IPF/CC uses of Ifenprodil. We will see.
Back to 2022.
Sharp eyes caught that Ifenprodil enhanced cancer tumor treatment successes at a statistically significant level. Agn is active in pursuit of this now licensed IP ect.
Sharp leadership caught that there was successful research of micro dosing DMT for Stroke. That IP was licensed before others could grab it.
Congratulations to the Algernonn team. IMO. ..
No buts. Buy-Hold-Sell...GLTA...
.
and.... No one is right all the time in for-sight. But.?.
AGN shareholders again have chances at successes, IMHFO.
I still occasionally provide management with my suggestions and opinions. I have also received acknowledgement of receipt of emails, no insider stuff. I assume they are read and not instantly 'blocked' or 'trashed'.
Both Golden Rules in mind.?.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149241870
My thoughts to the respected investor from the pre 12/15/20 fubar. Help take it to 20+ and change the math.
I was trounced for my suggestions years ago. Recently too, sell the POC tech, in house cobra deal or whatever. We're not at the decision level, only on the shares we have. Hope for the best, buy hold sell. A huge inflection point approaches. Interesting comments around this time at BTH/AGN.
...GLTA...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149233037
So you're holding for $30. If we get there the fun has just started and many will take some $ off the table. (as I said before). BUT the longer term rewards maybe much better. Speculative investment.
BTW, when Yost bailed Bth was headed for BK and without NASH/repurposing concepts/'deal' this would have been over then.
I came to Blo/then Bth from IMSC after it's ETD/NTD faims tech was stole by L3. Manure happens.
Of course management will issue themselves shares in the IPO. Why not longs too.?.
They will start 3 trials asap if approved, IMO . DMT Pump/a non dilutive financing deal for cancer tumor researchs/good IPF/CC news will get your $30. Easy. Why then suggest $9M @<$5 financing in a one fell swoop deal. That's not how I read it.?. From whom? Really.
OT, US/EU LNG deal...
10% + of total US Production to EU + +.?. I think this War will have long term benefits to stimulate US domestic NG/RNG use and provide over all demand increases. Double? maybe...GLTA...
https://www.bing.com/videos/search?q=Pres+Biden+NG+deal+with+EU&qpvt=Pres+Biden+NG+deal+with+EU&FORM=VDRE
So, you continue to hold like the rest of us.?.
Obviously AGN needs a significant Splash for an IPO that might reward long time shareholders and provide for bonuses along with the authorizing of shares to sell to pay for a couple Trials/Studies. ...GLTA...
Are you suggesting a SPAC thru Xortex
I am holding too as most that post here are doing. Holding a stock implies that the holder expects the company to succeed and provide profit as an investment. Holding a stock seems an active investment decision. IMO.
So someone says, AGN has to/will raise the full $9M immediately, before any news is released on SCLC/Pancreatic Cancer tumors trial approvals, before any plans are approved from MHRA dealing with microdose DMT for Stroke and specifics at Hammershmit, also before any news will be released on the progress and data from the IPF/CC clinical trial or non dilutive financing proposals have any time to flesh out, and before moving forward on a Nasdaq listing IPO with the only issues management are considering is raising as much as possible at the lowest PPS, and not considering fully the sequence of news or priorities or which provides the best 'bang for the bucks' or has the best chance for success ( short term or long term) and of course IF this all happens as seen through someone's crystal balls, there wont be any PPS appreciation and current shareholders wont receive any benefits as the IPO occurs .?.
Just checking for further details from other investors, especially from folks that have 'held' the stock for a long long time. . Always nice to see courteous respectful rational replies to/from other investors or posters at message boards.
...GLTA...
" Surely, once the uplist and crushing finance happens it'll be onto something else wild and outlandish as if the clueless episodes never happened."
My Reply would be.
WTH? SCLC/Tumors, IPF/CC, Stroke. Nasdaq IPO...Seems like a full hand for some time, IMO. Financing proxy is conditional on the Nasdaq move. AGN could make a Nice Big Splash with those IPO cards, IMO.
"I would assume one doesn't necessarily need to sit wit the CEO to establish a communication. Try using email or pick up the phone."
My Replies are.
I have invested and will HOLD with trust that the company is working toward it's short and long term Goals on their stated current initiatives. (Holding a stock is an Active investment decision!).
Everyone occasionally Emails to PR depts/management expressing ideas and support or not.
Like most investors I might try to Sell some AGN shares IF I thought there were insurmountable or new major negative issues in any of the three current initiatives, Stroke, IPF/CC, Cancer Tumors.
I may Buy some more as positive news occurs. I'm Holding my shares right now. (Holding shares is an active investment decision). Anticipating Positives...
Folks usually hold if their DD/Risks vs Rewards suggests the company may succeed. Me too.
I propose a way that could eventually reward shareholders better, IMO. The percentage of current shareholder ownership is important of course too. I stressed patience until After some successes and some paths are clearer. Then a Nice IPO Splash into the Nasdaq...
...GLTA...
Raising financial support and share structure changes are normal during an IPO up-list.
It is usually directly related to company's business changes/successes.
AGN plans an up-list AFTER news about significant progress in one or more of it's current initiatives.
The size and price will be determined by the magnitude and future possibilities presented in relation as to what the market will accept/support.
Companies succeed with an up-list when there is significant value. I hope for flesh on the bone Before a move.
Investors can Buy if confident, Sell if they are suspect or Hold and do Nothing which is also an active decision...
BTW again, I seldom drink and never beer, I dont know any Canadians and have never been there. Hindsighted Winers PMO as they blame others for personal decisions. Veterans say you're WELCOME FOR OUR SUPPORT of Free Speech Rights and take abuses of these Rights and personal insults the same as common citizens.
Pissing verbally in the common soup bowl repeatably is a Right, I guess???
...GLTA...
The Prospectus is for after a Nasdaq move. I dont see a single source financing for $5M at an <$8M MC. No need either, Unless there are successes to pursue.
Then?
Good news that is well handled could move the small 1.7M OS fast, maybe even to $30+(+) with a $50M+ MC.
Many will take some profits and some may leave forever. IF.
Some may hold or buy into positive possibilities of the NASDAQ IPO and hopefully an AGN that will be making a Big SPLASH there.
Money WILL be raised. The company will issue shares to sell and for bonuses. Shareholders deserve proportionate rewards. An IPO typically may provide opportunities.
This isnt tsla or appl but the theory is 3 - $15 shares will double faster than a $45 share. They'll need $10M + to run stuff eventually.
But, the portfolio AGN has may prove Huge.
No successes on the current initiatives equals a sh*t sandwich. JMHFO.
...GLTA...
Successes on some or at least ONE of the current initiatives is the goal for a move to a NASDAQ listing IPO.
Rewarding long shareholders with a larger proportion of the total OS should be a goal too. IMO. Raising money to further successful current initiatives is a given. How that is handled appears in debate here.
Sponsors are another possibility with Stroke and Cancer tumors, certainly of high interest and demand by medical communities. IPF and CC solutions for all us smokers?
Often folks/companies/investors/etc learn from the past and of course we ALL want financial successes...GLTA...
OT...
Silly that Russia seems to have forgotten the issues/tactics of current ground Warfare against foreign invader troops, like snipers and IEDs, personal anti-armor weapons like Javelins and shoulder fired Stingers against attempted Air superiority.
Ukraine is as large as Texas and getting armed better by the day. In spite of late actions from the EU and US.
A wall built across the southern US border with Mexico cannot stop immigrants or drugs etc. Canada is basically an unguarded border. WE lost to dudes in caves in Afghanistan. ESAD Mr Putin...JMHFO...
I thought I was clear about my wish list of a forward share increase...
repost/edit>
I'm saying 2 for 1 is 3.35M + 1.6M for capitol raise (etc) = 5m total OS.
or,
3 for 1 = 5 M + 1M for capitol raise = 6M total OS. Initiated After good news and as Nasdaq listing occurs. Possible...
,if there is sufficient progress/pump to get to $30+. Presumably timed with the Nasdaq move and offering...
Good news on One or more initiative and there are chances long shareholders will profit well.
!!!
You/folks cant think AGN goes to Nasdaq @$4 with 1.7M OS? I cant see that money will be raised Before there are "actual successes to chase and specific plans being formulated" to raise money for.?.
Really?!!! Stroke, Cancer Tumors, IPF/CC and CKD are all possibly huge. IMHFO.
Bad news on current initiatives and all will enjoy a big bite of the sh*t sandwich. ie, raising money after flops at <$4 will really taste sh*tie.
Deep dives reiterating possible worst case scenarios and airing past peeves? Plastered everywhere ad nauseum. GLWT...
Just My Opinion on a Possibility...GLTA...
BTW, in response to the 80% Rumanian COVID enrollment comment, the results have been posted for a while. I have respect that the COVID Trial was completed in spite of the world's closure.*
https://www.clinicaltrials.gov/ct2/show/results/NCT04382924
"Region of Enrollment
Measure Type: Number
Unit of measure: Participants
Number Analyzed 52 participants 56 participants 60 participants 168 participants
Romania 29 29 30 88
United States 7 10 12 29
Philippines 15 17 18 50
Australia 1 0 0 1
BTW2 South Korea now has 7M+ COVID cases yet when AGN attempted to run their first COVID Ifenprodil CT there, getting enough patients weas the problem. Probably caused by our CEO and those 'Cobraz' somehow...GLTA...
I'm saying 2 for 1 is 3.35M + 1.6M for capitol raise (etc) = 5m total OS, or, 3 for 1 = 5 M + 1M for capitol raise = 6M OS. Initiated After good news and as Nasdaq listing occurs. Possible...
Good news on One or more initiative and there are chances long shareholders will profit well.
Bad news on all initiatives and all will enjoy a big bite of the sh*t sandwich.
You/folks cant think AGN goes to Nasdaq @$4 with 1.7M OS? That money will be raised Before there are actual successes to chase and specific plans being formulated.?. Really?
Deep dives reiterating possible worst case scenarios and airing past peeves? Plastered everywhere ad nauseum. GLWT...
...GLTA...
Hmmm, approval news about Micro dose DMT for Phase 1 Stroke due. Geno testing for Ifenprodil Phase 2 SCLC/Pancreatic tumor, also due. IPF and related CC Phase 2 Study readout due with a follow up CC Phase 2. Hmmm.
The combination of current initiatives MAY be successful individually or consecutively and with proper positive enthusiasm ('pump') MAY enable shared successes for shareholders, MAYBE enabling Nasdaq listing with a strong tailwind, possibly a 2+ for 1 to existing shareholders at 6M shares OS with plenty of room for the proposed financing. $30+. Things just MAY go Good!
If some or alot goes wrong the Sh*t will stink proportionately. Obviously, it all is about which way the wind blows. Bragging or whining will be after the facts are known.
Buy, Hold or sell...
AGN is a speculative investment/ Small/ Micro cap Pharma company. We are all waiting. Loud and frantic or acknowledging Risks taken vs Possible Rewards...GLTA...
Some walked it down with lunch money selling and bids. Sad, IMHFO. Less than $5k.
Bet on actual news...GLTA...
Sad. POS JJ professional scam artist. Sad for GEM. Sad for all those that suffered in need and thru this person's greed/incompetence's. billion$ lost in RLF/NRX. Lives too, IMO.
These kinds of criminals seldom are punished, but a dude with a joint goes to jail.
I hope he gets cancer in his lying mouth and demented brain, then burns in Hell. JMHFO...GLTA somewhere else.
"The results are so compelling that we are in discussion with multiple energy companies to start initiating paid test wells that, in turn, will bring revenue to PCT second quarter," Grieco emphasized.
...GLTA...
Buy, hold, sell a speculative investment. Yup.
Pre-whine, obfuscate? Flip/short/personal agenda issues? For some.
UK Stroke clinical trial approvals thru MHRA, Due.
CC/IPF readouts expected in 2nd Q. The long trial may benefit results from the IPF portion, IMO.
Ifenprodil cancer tumor treatment, non dilutive funding / other - interest - support.?. Possible Successful Cancer tumor treatment IS a Big deal.
Probably ALL Prior to an uplist to the Nasdaq. IMO...
Progress on the new CKD initiative and more progress on Some/ALL of the above items, probably immediately before the uplist.
'the right time'
Prospectus conditional on Nasdaq uplist. 2/1 + for Longs/friends/family on Nasdaq move.?.
$2M, on hand. probably less. No immediate need for large cash outflow unless successes in some of these initiatives.
Probably no CT in Rumania or the Ukraine. JMHO...GLTA...
Recent news of the prospectus for post Nasdaq funding and the CEO speaking of picking the 'right time'. Maybe things will be going well enough for shareholders to get 2/1 in the deal when AGN moves.
Finally moving forward now with the 'NASH deal' drug for CKD with an initial GMP contract.
Of course, expected news from the UK on the Micro-dose DMT MHRA applications for their stroke Clinical trials.
Good new interview folks should watch for themselves. JMHO...GLTA...
The way I read this is that nothing will happen until AFTER a Nasdaq up-listing.
As of February 16, 2022, the last reported sales price of our Common Shares on the OTCQB was US$5.10 per share, and on February 16, 2022 we had 1,674,868 Common Shares outstanding. We intend on applying to have our Common Shares and Warrants listed on the Nasdaq Capital Market under the symbols "[?]" and "[?]", respectively, which listing is a condition to this offering. Our application might not be approved. There is no established public trading market for the Warrants included in the units, and such a market might never develop.
.0003% of float.?. OMG. Panic sell. and that January short was probably in the $4s, + costs.
I'm leaning more toward success in the UK through the licensed Micro- dose DMT IP for Stroke from Dartmoth, with support in presentations to the MHRA from UK Stroke experts Dr Rudd and Dr Simister.
and so much more with Ifenprodil MOA on CC/IPF/Cancer tumors.
Buy, hold, sell(short)...GLTA...
Combined Clinical Trial of Investigational Medicinal Products and Ethics Approval...
Assessment of your submission
The initial combined review assessment will be completed within 30 days of being submitted. Applications for healthy volunteer trials and sponsor-determined phase I trials in non-oncology patients may qualify for a shortened assessment time and MHRA will work with the research ethics committee to endeavour to expedite these applications. You should state on your covering letter if you think your trial is eligible. Note that trial designs that stretch to investigating the benefit of the treatment to participants may not be eligible for the expedited assessment timeframe.
We will tell you the outcome of your submission along with the outcome of the research ethics committee review, via the combined review process, which could be:
acceptance of the request for a clinical trial authorisation
acceptance of the request for a clinical trial authorisation subject to conditions
grounds for non-acceptance of the request for a clinical trial authorisation
If we raise grounds for non-acceptance you will have the opportunity to respond, usually within 14 days; however this may be extended on request.
Communication informing the applicant of the MHRA and ethics committee decision following receipt of the responses will usually be sent within 60 days of us receiving the original valid application. If an extension to the response date has been agreed this will impact the final decision timeline.
30 days for initial response from 01-19-2022. This may go fast...GLTA...
https://www.globenewswire.com/news-release/2022/01/19/2369181/0/en/Algernon-Pharmaceuticals-Files-for-Clinical-Trial-and-Ethics-Approval-for-Phase-1-DMT-Human-Stroke-Study.html
Someone has opined often in the past to do an 'inside' paper deal with the BTH IP to our 'sister'.*. This would clean up the IP for them and get operating $ for AGN.
Yost still stole BTH work when he slid to Owlstone. Sucks but BTH couldn't produce a product. ie>NASH>AGN...
Irrelevant?
IPF/CC may hit a couple end-points...
Currently strong support in the UK with top of the line folks involved in the microdose DMT clinical trial. It could progress fast. Maybe...
Cancer research is often for 'possible' terminal patients. There is funding support and continuous research efforts for solutions, especially in the USA.
Seems we've possibly passed the lows after consolidation and folks may look ahead. A fair+ Risk to Reward, IMO.
...GLTA...
* 5M shares @ $.5. Bonuses to BODs included.
Interesting investment discussion today with diverse opinions.?
Shorting cycle again on 'cobra' stocks, I guess? GLWT. Amazing.
and or.
Power investment tactics of dominating discussions on many message boards from 'it's-spaced'. GLWT...
let's not forget the anti depressants and an 81mg aspirin for blood pressure. Redbull/Whiskey/nyquil cocktails again to wash them down? GLWT.
Obfuscating the Same Old S* about missed personal decision$ to now respond in hind-sight.
The point is that AGN has at least 3 fair to great chances at success. IMO.
BTW, as I've said before I dont know or talk with anyone in Canada. I seldom/never drink acl. I would guess some folks rag regularly.
Most/ALL took a hit after the Dec 15 2020 MW disastrous 'interim' 'halt' 'presentation'.
Some shareholders had just placed large bets and are probably still here too. Personal decisions. NO ONE was Forced.
Good *uck Sir
Ha, Crazy is excessive complaining about a 2017 investment while holding through its several iterations/businesses without apparently making any deci$ion$ of either taking profits/limiting losses or looking at future prospects and changing positions and/or tactics.
Sour whine with a molded 'ham' are not most folks' favorites...
Doing nothing IS an option but it's Crazy to blame others for the results.
Buy-hold-sell are the options.
Crazy is Demanding respect while eternally denigrating the company's efforts and decisions. I dont remember seeing any guarantees, just stated efforts toward possible success.
See the links I posted, this is Not a one trick psyc trip.
Urinating on the playing table is usually frowned on and reduces other folks' respect for that continuous M.O., IMO.
SCLC/pancreatic tumors,
IPF/CC,
Stroke,
IBD and CKD...
...GLTA...
No I am looking forward to Cancer therapies, Stroke therapies and Cronic cough therapies.
Buy some 'newbie' shares', it's called averaging, DUH.
This is NOT a dead end psyc only play.
My post was intended to be a positive - forward looking opinion backed with easy DD.
And you can only see negatives from those links and about the company future? Really.
...GLTA...
near term events. Hmmmmmmmm...
With good feedback from the pre IND meeting with the FDA about the SCLC/pancreatic tumor trials,, what happens next.?.
https://www.globenewswire.com/news-release/2021/11/24/2340463/0/en/Algernon-Pharmaceuticals-Announces-Positive-Feedback-from-U-S-FDA-for-Phase-1-Ifenprodil-Small-Cell-Lung-Cancer-Study.htm
Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough
Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough
VANCOUVER, British Columbia, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB: AGNPF) a clinical stage pharmaceutical development company, is pleased to announce that it has completed enrollment in its Phase 2 NP-120 (“Ifenprodil”) idiopathic pulmonary fibrosis (“IPF’) and chronic cough study. The Company is projecting a data readout in calendar Q2, 2022.
https://www.globenewswire.com/news-release/2022/01/28/2374942/0/en/Algernon-Pharmaceuticals-Announces-Notice-of-Allowance-for-Ifenprodil-Patent-Application-for-Idiopathic-Pulmonary-Fibrosis.html
https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Announces-Positive-Feedback-from-US-FDA-for-Phase-2b-Ifenprodil-Chronic-Cough-Study?id=339117
UK MHRA decision/approval of the Stroke Phase 1 clinical trial.
Dr Simister, Dr Rudd, Dr Nutt, Dr Strassman.!.!.!.
l
With IBD and CKD drugs from NASH for other future paths of long term value. Hmmm...GLTA...
I bet managers and developers enjoyed their criminally connived positions at GOOG that they sold us out for.
Keys to the Video internet CODEC sold for $.75 and jobs @goog for management, created hundreds of billion$ with Youtube/etc...
Goog is still fighting against some shareholder compensation in courts, re. ON2shareholdersettlement.com...
"""
Wednesday, August 05, 2009 10:36ET
Aug 05, 2009 (SmarTrend(R) News Watch via COMTEX) -- 8/5/2009 - On2 Technologies, Inc. (AMEX:ONT) and Google Inc. (NASDAQ:GOOG) announced Wednesday that they have entered an agreement under which Google will acquire On2. Under the terms of the agreement, each outstanding share of On2 common stock will be converted to 60 cents worth of Google class A common stock in a stock-for-stock transaction, representing a 57% premium over On2's last close. The total transaction is valued at about $106.5 million. Vice president of Product Management with Google, Sundar Pichai, said, "Today video is an essential part of the web experience, and we believe high-quality video compression technology should be a part of the web platform. We are committed to innovation in video quality on the web, and we believe that On2's team and technology will help us further that goal." Interim CEO of On2, Matt Frost, said, "We're thrilled that On2 is joining one of the world's most innovative companies. After intensive review of On2 products, Google confirmed our long-held beliefs as to the quality of our video technologies. This transaction is a testament to the hard work of every On2 employee and the strongest possible endorsement of our products and people. On2 will continue to improve, support and sell our products throughout the transition. We believe that Google shares our ambitions and know that our products and expertise, combined with Google's globally recognized brand, ingenuity and resources, will create an incredible team."
Fuck ONT shareholders, long live GOOG...GLTA...Some where else...
Sad but true, IMO. We should have paid attention to Tony V as he left. He sold @ $.25 and started a Cal farm. as. The rest of us listened about a new patent for no-chemicals' extraction processes, PRANNA and lawsuits over original formulation for CBDs/THCs. Good stuff and I believed/pumped/invested... Sorry...
But hail storms, bad plantings, LACK OF POT to process, court expenses and worse management. etc.?.?. 14M share bonuses.?.
This WAS a "first in" cannabis company and they Fktitup.
First for Medical MJ/CBD.?.
It should have been more than a speculative hope and then BK. ?
I blame me most. I lost on a couple COVID specs recently but have since doubled down due to their drugs' futures and a secondary psyc medical uses
...GLTA... Somewhere else.